Skip to main content
Clinical Trials/NCT00570219
NCT00570219CompletedNot Applicable

The Effect of Valproate Treatment on Withdrawal Severity in Benzodiazepine Dependent Opioid Maintenance Treatment Patients

University of Helsinki1 site in 1 country30 target enrollmentStarted: February 2005Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
30
Locations
1
Primary Endpoint
benzodiazepine withdrawal severity

Study Overview

Brief Summary

The aim of this study is to determine whether valproate is effective in the treatment of benzodiazepine withdrawal symptoms in subjects receiving maintenance treatment for opiate dependence.

Detailed Description

In Finland, 90% of subjects with opioid dependence are dependent on benzodiazepines too. Concurrent use of opioids and benzodiazepines has increasingly caused deaths.

Benzodiazepine withdrawal treatment usually comprises gradual drug discontinuation. In one study, valproate was shown to improve benzodiazepine discontinuation success in chronic benzodiazepine users. In the present study, the effectiveness of gradual benzodiazepine discontinuation combined with valproate treatment and carried out in an inpatient setting is compared with gradual discontinuation without pharmacological augmentation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Diagnosis of benzodiazepine dependence (DSM IV-R)
  • Induction of buprenorphine or methadon maintenance treatment, or need of benzodiazepine withdrawal treatment during ongoing buprenorphine/methadon maintenance

Exclusion Criteria

  • Pregnancy
  • History of convulsions
  • Unstable somatic diseases

Arms & Interventions

B

Experimental

Gradual benzodiazepine discontinuation and valproate treatment

Intervention: valproate (Drug)

Outcomes

Primary Outcomes

benzodiazepine withdrawal severity

Time Frame: 3 weeks

Secondary Outcomes

  • attrition from treatment(3 weeks)
  • benzodiazepine use(4 weeks after treatment)

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials

The Effect of Valproate on Benzodiazepine... | Clinical Trial